Related Experiment Video

Updated: May 12, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Erectile dysfunction in the cardiovascular patient

Charalambos Vlachopoulos1, Graham Jackson, Christodoulos Stefanadis

  • 11st Department of Cardiology, Hippokration Hospital, Athens Medical School, Profiti Elia 24, Athens 14575, Greece. cvlachop@otenet.gr

European Heart Journal
|April 26, 2013
PubMed

Insights

Erectile dysfunction is a common sign of cardiovascular disease and an independent risk factor for future heart events. Addressing sexual health is crucial for cardiovascular risk assessment and management in men.

Area of Science:

  • Cardiology
  • Urology
  • Sexual Medicine

Background:

  • Erectile dysfunction (ED) is highly prevalent in patients with cardiovascular disease (CVD).
  • ED significantly impacts quality of life and serves as an independent predictor of future cardiovascular events.
  • A notable time lag exists between ED onset and cardiovascular event manifestation, offering a window for intervention.

Purpose of the Study:

  • To review the intricate relationship between ED and CVD.
  • To evaluate the implications of this connection for clinical practice.
  • To propose management strategies for ED patients based on cardiovascular risk.

Main Methods:

  • Literature review focusing on the link between ED and CVD.
  • Analysis of ED as a cardiovascular risk marker.
  • Development of clinical algorithms for ED management incorporating CVD risk assessment.

Main Results:

  • ED is a critical early indicator of underlying vascular dysfunction.
  • Comprehensive cardiovascular risk reduction strategies benefit both vascular health and sexual function.
  • Sexual counseling enhances patient quality of life and treatment adherence.

Conclusions:

  • Sexual function assessment should be integrated into routine cardiovascular risk evaluation for men.
  • Holistic cardiovascular risk management improves ED and overall health outcomes.
  • Structured approaches to ED management can mitigate future cardiovascular risks.

Keywords:
Cardiovascular diseaseErectile dysfunctionSexual counselling

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...